
Dorry Segev
Vice Chair, Department of Surgery and the Surgical Sciences · NYU Grossman School of Medicine
Credentials: · · · · ·
History
PresentDepartment of Surgery and the Surgical Sciences · NYU Grossman School of Medicine
PresentCenter for Surgical and Transplant Applied Research · NYU Grossman School of Medicine

- 1992–1996
Research
Frailty as a predictor of surgical outcomes in older patients
Journal of the American College of Surgeons · 2010 · 1,633 citations
American Journal of Transplantation · 2018 · 865 citations
Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients
JAMA · 2021 · 843 citations

197 papers · 23 as a resident

144 papers
- WW
113 papers · 92 as a fellow

100 papers

97 papers

96 papers · 47 as a resident

83 papers
- BB
83 papers · 70 as a resident
Grants
- 2026–2033
HOPE Heart Study: A Clinical Trial of HIV to HIV Transplantation
National Institute of Allergy and Infectious Diseases · U01
Contact PI · $1.7M · New York University School of Medicine
- 2026–2031
National Institute on Aging · R01
PI · $1.4M · New York University School of Medicine
- 2026–2031
National Institute of Allergy and Infectious Diseases · P01
PI · $2.1M · New York University School of Medicine
- 2018–2030
Expanding HOPE Liver Transplantation: Understanding Opportunistic Infection and Cancer Risk
National Institute of Allergy and Infectious Diseases · U01
PI · $25.5M · Johns Hopkins University
Clinical trials
- 2026–2030
Study chair · Recruiting
National Institute of Allergy and Infectious Diseases (NIAID)
- 2023–2024
COVID Protection After Transplant - Sanofi GSK (CPAT-SG) Study
Study chair · Completed · Phase 2
National Institute of Allergy and Infectious Diseases (NIAID)
- 2021–2025
COVID Protection After Transplant-Immunosuppression Reduction
Study chair · Completed · Phase 2
National Institute of Allergy and Infectious Diseases (NIAID)
- 2021–2023
COVID-19 Protection After Transplant Pilot Study
Study chair · Completed · Phase 2
National Institute of Allergy and Infectious Diseases (NIAID)


